ropivacaine hydrochloride NDC 25021-671

NDC codes

FDA NDC Directory

Product NDC (as listed)25021-671Labeler and product segments. Claims need a package NDC.

Product NDC at billing width25021-0671Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
25021-671-82	25021067182	10 BAG in 1 CARTON (25021-671-82) / 100 mL in 1 BAGMarketed from Dec 15, 2018
25021-671-87	25021067187	10 BAG in 1 CARTON (25021-671-87) / 200 mL in 1 BAGMarketed from Dec 15, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): ropivacaine hydrochloride
Generic name (nonproprietary): ropivacaine hydrochloride
Active ingredients: Ropivacaine hydrochloride — 2 mg/mL
Dosage form: Injection, Solution
Route: Epidural, Infiltration
Labeler: Sagent Pharmaceuticals
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206166
Marketing start: Dec 15, 2018
Listing expires: Dec 31, 2027
Other FDA classes: Amides (Chemical structure)Local Anesthesia (Physiologic effect)
Identifiers: Product ID 25021-671_41f4446a-ca6e-465e-9a79-8c4f99eb1ac3SPL ID 41f4446a-ca6e-465e-9a79-8c4f99eb1ac3SPL set ID 8c5c762f-d266-4b1a-809e-f11bfc89bc2dRxCUI 1734347, 1734355, 1734479, 1734481UNII V910P86109
Pharmacologic class: Amide Local Anesthetic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N425021067182 followed by a unit qualifier and the quantity

Package 25021-0671-82. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 6, 2025.

Indications (excerpt from the label)

Ropivacaine Hydrochloride Injection is indicated for the production of local or regional anesthesia for surgery and for acute pain management. Surgical Anesthesia : epidural block for surgery including cesarean section; major nerve block; local infiltration Acute Pain Management : epidural continuous infusion or intermittent bolus, e.g., postoperative or labor; local infiltration Ropivacaine Hydrochloride Injection is an amide local anesthetic indicated in adults for the production of local or regional anesthesia for surgery and for acute pain management ( 1 ). Surgical Anesthesia : epidural block for surgery including cesarean section; major nerve block; local infiltration ( 1 ) Acute Pain …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 206166

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206166
Product	Strength	Form · route	Labeler	Product NDC
ropivacaine hydrochloride	Ropivacaine hydrochloride 5 mg/mL	Injection, SolutionEpidural, Infiltration	Sagent Pharmaceuticals	25021-652